Allogene Therapeutics Inc’s recent filing unveils that its SVP, Finance Yoshiyama Annie unloaded Company’s shares for reported $13537.0 on Apr
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Allogene Therapeutics Inc’s recently made public that its SVP, Finance Yoshiyama Annie unloaded Company’s shares for reported $13537.0 on Apr
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics
Allogene Therapeutics Inc’s filing revealed that its SVP, Finance Yoshiyama Annie unloaded Company’s shares for reported $13537.0 on Apr 21
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics
Allogene Therapeutics Inc’s recent filing unveils that its SVP, Finance Yoshiyama Annie unloaded Company’s shares for reported $13537.0 on Apr
Allogene Therapeutics Inc’s recently made public that its Officer Yoshiyama Annie acquired Company’s shares for reported $13537.0 on Apr 21
Allogene Therapeutics Inc’s recent filing unveils that its President and CEO Chang David D unloaded Company’s shares for reported $91469.0
Allogene Therapeutics Inc’s recent filing unveils that its President and CEO Chang David D unloaded Company’s shares for reported $91469.0
